Explore
Validate
LearnHPA031573
antibody from Atlas Antibodies
Targeting: MAGED2
11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA031573 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA031573, RRID:AB_10602181
- Product name
- Anti-MAGED2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human MAGED2, Gene description: melanoma antigen family D, 2, Alternative Gene Names: 11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386, Validated applications: ICC, IHC, WB, Uniprot ID: Q9UNF1, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.4 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Polyhydramnios, Transient Antenatal Bartter’s Syndrome, andMAGED2Mutations
Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy.
Laghmani K, Beck B, Yang S, Seaayfan E, Wenzel A, Reusch B, Vitzthum H, Priem D, Demaretz S, Bergmann K, Duin L, Göbel H, Mache C, Thiele H, Bartram M, Dombret C, Altmüller J, Nürnberg P, Benzing T, Levtchenko E, Seyberth H, Klaus G, Yigit G, Lin S, Timmer A, de Koning T, Scherjon S, Schlingmann K, Bertrand M, Rinschen M, de Backer O, Konrad M, Kömhoff M
New England Journal of Medicine 2016;374(19):1853-1863
New England Journal of Medicine 2016;374(19):1853-1863
Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy.
Hashimoto R, Kanda M, Takami H, Shimizu D, Oya H, Hibino S, Okamura Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Kodera Y
Oncology letters 2015 Mar;9(3):1201-1206
Oncology letters 2015 Mar;9(3):1201-1206
No comments: Submit comment
Enhanced validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Recombinant expression validation
- Main image
- Experimental details
- Western blot analysis in control (vector only transfected HEK293T lysate) and MAGED2 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells, LY415179).
- Sample type
- Human
- Protocol
- Protocol
